Method for Trans-Differentiating Non-Neuronal Cells into Neurons
Summary
The USPTO has published a patent application (US20260085284A1) from SHANGHAI GENEMAGIC BIOSCIENCES CO., LTD. for a method of trans-differentiating non-neuronal cells into neurons using specific regulators. The application was filed on August 30, 2023.
What changed
This document is a published patent application detailing a method for converting non-neuronal cells into neurons. The method involves using specific negative or positive regulators to influence gene expression, thereby inducing trans-differentiation. The application, filed by SHANGHAI GENEMAGIC BIOSCIENCES CO., LTD., outlines specific genes and regulators involved in this process.
As this is a patent application, it does not impose immediate compliance obligations. However, it signifies potential future developments in regenerative medicine and cell therapy. Companies operating in the biotechnology and pharmaceutical sectors should monitor the progress of this and similar patent applications as they may impact future research, development, and commercialization strategies in neuroscience and cell-based therapies.
Archived snapshot
Mar 27, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
METHOD FOR TRANS-DIFFERENTIATING NON-NEURONAL CELLS INTO NEURONS AND USE THEREOF
Application US20260085284A1 Kind: A1 Mar 26, 2026
Assignee
SHANGHAI GENEMAGIC BIOSCIENCES CO., LTD.
Inventors
Haibo ZHOU, Xinde HU, Jinlin SU
Abstract
Provided is a method for trans-differentiating non-neuronal cells of a mammal into neurons. The method comprises: providing a negative regulator capable of reducing the expression of negative regulatory genes, the negative regulatory gene including RCOR1, RCOR2, RCOR3, Sin3a, Sin3b, HDAC1, HDAC2, KDM1A, PHF21A, BAF53a, G9a, USP14, HuR, BrG1, EZH2, CDYL, or HMG20B; and/or providing a positive regulator capable of improving the expression of positive regulatory genes, the positive regulatory genes including DPYSL2, BAF45b, SCF, HuB, HuC, HuD, CYP1B1, or BTRC. An effective amount of the negative regulator or the positive regulator contacting the non-neuronal cells can induce trans-differentiation of the non-neuronal animal cells into neurons.
CPC Classifications
C12N 5/0619 A61P 27/02 C12N 9/226 C12N 15/11 C12N 15/86 C12N 15/907 C12N 2310/20 C12N 2506/08 C12N 2510/00 C12N 2750/14143
Filing Date
2023-08-30
Application No.
19107933
Related changes
Get daily alerts for USPTO Patent Applications - Biotech (C12N)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Biotech (C12N) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.